Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Nanjing Medical UniversityActive in the last 2 years

Zhuyin Qian

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9709-4829; OpenAlex author ID A5041557013. Sources: OpenAlex.

Their work

Papers
10 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
27
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 2 papers · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 2 papers · 2021: 1 paper · 2022: 2 papers · 2023: none · 2024: none · 2025: 1 paper

Papers 10

  1. Editorial expression of concern: Yin Yang-1 suppresses invasion and metastasis of pancreatic ductal adenocarcinoma by downregulating MMP10 in a MUC4/ErbB2/p38/… Co-author DOI 10.1186/s12943-025-02326-6↗
  2. Laparoscopic ultrasonography-guided cryoablation of locally advanced pancreatic cancer: a preliminary report. Last author DOI 10.1007/s11604-021-01175-9↗
  3. Detection of serum EphA2-EVs for pancreatic cancer diagnosis by light initiated chemiluminescent assay. Co-author DOI 10.1039/d1ay02083h↗
  4. Long Intergenic Nonprotein Coding RNA 173 Inhibits Tumor Growth and Promotes Apoptosis by Repressing Sphingosine Kinase 1 Protein Expression in Pancreatic Canc… Last author DOI 10.1089/dna.2020.6103↗
  5. Comparative peptidome profiling reveals critical roles for peptides in the pathology of pancreatic cancer. Last author DOI 10.1016/j.biocel.2020.105687↗
  6. Metformin Increases the Chemosensitivity of Pancreatic Cancer Cells to Gemcitabine by Reversing EMT Through Regulation DNA Methylation of miR-663. Last author DOI 10.2147/ott.s261570↗
  7. Yin Yang-1 suppresses invasion and metastasis of pancreatic ductal adenocarcinoma by downregulating MMP10 in a MUC4/ErbB2/p38/MEF2C-dependent mechanism. Co-author DOI 10.1186/1476-4598-13-130↗
  8. Comprehensive analysis of the percentage of surface receptors and cytotoxic granules positive natural killer cells in patients with pancreatic cancer, gastric … Co-author DOI 10.1186/1479-5876-11-262↗
  9. CEACAM6 induces epithelial-mesenchymal transition and mediates invasion and metastasis in pancreatic cancer. Co-author DOI 10.3892/ijo.2013.2015↗
  10. Galectin-1 secreted by activated stellate cells in pancreatic ductal adenocarcinoma stroma promotes proliferation and invasion of pancreatic cancer cells: an i… Co-author DOI 10.1097/mpa.0b013e318217945e↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yuqing Gu · 4 shared papers, 2020–2022 · strength 0.57
  2. Zekuan Xu · 5 shared papers, 2011–2025 · strength 0.33
  3. Wentao Gao · 5 shared papers, 2011–2025 · strength 0.33
  4. Junli Wu · 5 shared papers, 2011–2025 · strength 0.33
  5. Kuirong Jiang · 5 shared papers, 2011–2025 · strength 0.33
  6. Yunpeng Peng · 3 shared papers, 2013–2025 · strength 0.28
  7. Yi Miao · 3 shared papers, 2013–2025 · strength 0.28
  8. Bin Zhang · 2 shared papers, 2020 · strength 0.25
  9. Kun-Ling Xie · 2 shared papers, 2014–2025 · strength 0.25
  10. Zheng Li · 2 shared papers, 2014–2025 · strength 0.25
  11. Jie Tang · 2 shared papers, 2014–2025 · strength 0.25
  12. Xingxing Li · 2 shared papers, 2020–2021 · strength 0.24
  13. Jingjing Zhang · 1 shared paper, 2025 · strength 0.21
  14. Yingchun Wu · 1 shared paper, 2022 · strength 0.19
  15. Wenhan Li · 1 shared paper, 2022 · strength 0.16
  16. Yefei Zhu · 1 shared paper, 2022 · strength 0.16
  17. Qian Li · 1 shared paper, 2021 · strength 0.13
  18. Jingjing Zhang · 2 shared papers, 2013–2014 · strength 0.07
  19. Yi Miao · 2 shared papers, 2011–2014 · strength 0.06
  20. Qiang Li · 2 shared papers, 2011–2013 · strength 0.05
  21. Yong An · 2 shared papers, 2011–2013 · strength 0.05
  22. Xiaofeng Xue · 2 shared papers, 2011–2013 · strength 0.05
  23. Jishu Wei · 2 shared papers, 2011–2013 · strength 0.05
  24. Jianmin Chen · 1 shared paper, 2013 · strength 0.03
  25. Zipeng Lu · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.